A naturally occurring mutation near the amino terminus of αIIb defines a new region involved in ligand binding to αIIbβ3

Blood

Volumn 95, Issue 1, 2000, Pages 180-188

  Basani, Ramesh B ^b   French, Deborah L ^b   Vilaire, Gaston ^b   Brown, Deborah L ^b   Chen, Fangping ^b   Coller, Barry S ^b   Derrick, Jerry M ^b   Gartner, T Kent ^b   Bennett, Joel S ^b   Poncz, Mortimer ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CHO CELL; FEMALE; GLANZMANN DISEASE; HUMAN; LIGAND BINDING; MALE; PRIORITY JOURNAL; THROMBOCYTE MEMBRANE;

EID: 0033964864     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.1.180.001k16_180_188     Document Type: Article

References (52)

1. Phillips DR, Charo IF, Parise LV, Fitzgerald LA. The platelet membrane glycoprotein IIb-IIIa complex. Blood. 1988;71:831-843.
2. Ginsberg MH, Xiaoping D, O'Toole TE, Loftus JC, Plow EF. Platelet integrins. Thromb Haemost. 1993;70:87-93.
3. Coller BS, Seligsohn U, Peretz H, Newman PJ. Glanzmann thrombasthenia: new insights from a historical perspective. Semin Hematol. 1994;31: 301-311.
4. French DL. The molecular genetics of Glanzmann's thrombasthenia. Platelets. 1998;9:5-20.
5. Ferrer M, Tao J, Iruin G, et al. Truncation of glycoprotein (GP) IIIa (616-762) prevents complex formation with GPIIb: novel mutation in exon 11 of GPIIIa associated with thrombasthenia. Blood. 1998;92:4712-4720.
6. Grimaldi CM, Chen FP, Wu CH, Weiss HJ, Coller BS, French DL. Glycoprotein lib Leu214Pro mutation produces Glanzmann thrombasthenia with both quantitative and qualitative abnormalities in GPIIb/IIIa. Blood. 1998;91:1562-1571.
7. Honda S, Tomiyama Y, Shiraga M, et al. A two-amino acid insertion in the Cys146-Cys167 loop of the αIIb subunit is associated with a variant of Glanzmann thrombasthenia. J Clin Invest. 1998; 102:1183-1192.
8. Jackson DE, White MM, Jennings LK, Newman PJ. A Ser162Leu mutation within glycoprotein (GP) IIIα (integrin β3) results in an unstable αIIbβ3 complex that retains partial function in a novel form of type II Glanzmann thrombasthenia. Thromb Haemost. 1998;80:42-48.
9. Ruan J, Peyruchaud O, Alberio L, et al. Double heterozygosity of the GPIIb gene in a Swiss patient with Glanzmann's thrombasthenia. Br J Haematol. 1998;102:918-925.
10. Scott JPI III, Scott JPI II, Chao Y-L, Newman PJ, Ward CM. A frameshift mutation at Gly975 in the transmembrane domain of GPIIb prevents GPIIb-IIIa expression: analysis of two novel mutations in a kindred with type I Glanzmann thrombasthenia. Thromb Haemost. 1998;80:546-550.
11. Kamata T, Irie A, Tokuhira M, Takada Y. Critical residues of integrin αIIb subunit for binding of αIIbβ3 (glycoprotein Ib-IIIa) to fibrinogen and ligand mimetic antibodies (PAC-1, OP-G2) and LJ-CP3). J Biol Chem. 1996;271:18,610-18,615.
12. Tozer EC, Baker EK, Ginsberg MH, Loftus JC. A mutation in the α subunit of the platelet αIIbβ3 identifies a novel region important for ligand binding. Blood. 1999;93:918-924.
13. Springer TA. Folding of the N-terminal, ligand-binding region of integrin α-subunits into a β-propeller domain. Proc Natl Acad Sci U S A. 1997; 94:65-72.
14. Poncz M, Rifat S, Coller BS, et al. Glanzmann thrombasthenia secondary to a Gly273→Asp mutation adjacent to the first calcium-binding domain of platelet glycoprotein IIb. J Clin Invest. 1994;93: 172-179.
15. Bennett JS, Hoxie JA, Leitman SF, Vilaire G, Cines DB. Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody. Proc Natl Acad Sci USA. 1983;80:2417-2421.
16. Weisel JW, Nagaswami C, Vilaire G, Bennett JS. Examination of the platelet membrane glycoprotein IIb-IIIa complex and its interaction with fibrinogen and other ligands by electron microscopy. J Biol Chem. 1992;267:16,637-16,643.
17. Shattil SJ, Hoxie JA, Cunningham M, Brass LA. Changes in the platelet membrane glycoprotein IIb-IIIa complex during platelet activation. J Biol Chem. 1985;260:11,107-11,114.
18. Montgomery RR, Kunicki TJ, Taves C, Pidard D, Corcoran M. Diagnosis of Bernard-Soulier syndrome and Glanzmann thrombasthenia with a monoclonal assay on whole blood. J Clin Invest. 1983;71:385-389.
19. Coller BS, Seligsohn U, Little PA. Type I Glanzmann thrombasthenia patients from the Iraqi-Jewish and Arab populations in Israel can be differentiated by platelet glycoprotein IIIa immunoblot analysis. Blood. 1987;69:1969-1703.
20. Shadle PJ, Ginsberg MH, Plow EF, Barondes SH. Platelet-collagen adhesion: inhibition by a monoclonal antibody that binds glycoprotein IIb. J Cell Biol. 1984;99:2056-2060.
21. Kutok JL, Coller BS. Partial inhibition of platelet aggregation and fibrinogen binding by a murine monoclonal antibody to GPIIIa: requirement for antibody bivalency. Thromb Haemost. 1994;72: 964-972.
22. Poncz M, Solowiejczyk D, Harpel B, Mory Y, Schwartz E, Surrey S. Construction of human gene libraries from small amounts of peripheral blood: analysis of β-like globin genes. Hemoglobin. 1982;6:27-36.
23. Heidenreich R, Eisman R, Surrey S, et al. Organization of the gene for platelet glycoprotein IIb. Biochemistry. 1990;29:1232-1244.
24. Zimrin AB, Gidwitz S, Lord S, et al. The genomic organization of platelet glycoprotein IIIa. J Biol Chem. 1990;265:8590-8595.
25. Villa-Garcia M, Li L, Riely G, Bray PF. Isolation and characterization of a TATA-less promoter for the human β3 integrin gene. Blood. 1994;83:668-676.
26. Basani RB, Vilaire G, Shattil SJ, Kolodziej M, Bennett JS, Poncz M. Glanzmann thrombasthenia due to a two amino acid deletion in the fourth calcium-binding domain of αIIb: demonstration of the importance of calcium-binding domains in the conformation of αIIbβ3. Blood. 1996;88:167-173.
27. Coller BS, Cheresh DA, Asch E, Seligsohn U. Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel. Blood. 1991;77: 75-83.
28. Block KL, Ravid K, Phung QH, Poncz M. Characterization of regulatory elements in the 5′-flanking region of the rat GPIIb gene by studies in a primary rat marrow culture system. Blood. 1994;84: 3385-3393.
29. Bonthron DT, Handin RI, Kaufman R, et al. Structure of pre-pro-von Willebrand factor and its expression in heterologous cells. Nature. 1986;324: 270-273.
30. Loh E, Beaverson K, Vilaire G, Qi W, Poncz M, Bennett JS. Agonist-stimulated ligand binding by the platelet integrin alpha IIb beta 3 in a lymphocyte expression system. J Biol Chem. 1995;270: 18,631-18,636.
31. Loh E, Qi W, Vilaire G, Bennett JS. Effect of cytoplasmic domain mutations on the agonist-stimulated ligand binding activity of the platelet integrin alphaIIbbeta3. J Biol Chem. 1996;271:30,233-30,241.
32. Tokuhira M, Handa M, Kamata T, et al. A novel regulatory epitope defined by a murine monoclonal antibody to the platelet GPIIb-IIIa complex (alpha IIb beta 3 integrin). Thromb Haemost. 1996;76:1038-1046.
33. Bennett JS, Shattil SJ, Power JW, Gartner TK. Interaction of fibrinogen with its platelet receptor: differential effects of α and γ chain fibrinogen peptides on the glycoprotein IIb-IIIa complex. J Biol Chem. 1988;263:12,948-12,953.
34. Derrick J, Taylor DB, Loudon RG, Gartner TK. The peptide LSARLAF causes platelet secretion and aggregation by directly activating the integrin αIIbβ3. Biochem J. 1997;325:309-313.
35. Coller BS, Peerschke EI, Scudder LE, Sullivan CA. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds glycoproteins IIb and/or IIIa. J Clin Invest. 1983;72:325-338.
36. Shadle PJ, Ginsberg MH, Plow EF, Barondes SH. Platelet-collagen adhesion: inhibition by a monoclonal antibody that binds glycoprotein IIb. J Cell Biol. 1984;99:2056-2060.
37. Kulok JL, Coller BS. Partial inhibition of platelet aggregation and fibrinogen binding by a murine monoclonal antibody to GPIIIa: requirement for antibody bivalency. Thromb Haemost. 1994;72: 964-972.
38. Cheresh DA, Spiro RC. Biosynthetic and functional properties of an arg-gly-asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor. J Biol Chem. 1987;262:17,703-17,711.
39. Kolodziej MA, Vilaire G, Rifat S, Poncz M, Bennett JS. Effect of deletion of glycoprotein IIb exon 28 on the expression of the platelet glycoprotein IIb/IIIa complex. Blood. 1991;78:2344-2353.
40. Derrick JM, Loudon RG, Gartner TK. Peptide LSARLAF activates alpha(IIb)beta3 on resting platelets and causes resting platelet aggregate formation without platelet shape change. Thromb Res. 1998;89:31-40.
41. Imai T, Yanase T, Waterman MR, Simpson ER, Pratt JJ. Canadian Mennonites and individuals residing in the Friesland region of the Netherlands share the same molecular basis of 17 alpha-hydroxylase deficiency. Hum Genet. 1992; 89:95-96.
42. Wilcox DA, Wautier JL, Pidard D, Newman PJ. A single amino acid substitution flanking the fourth calcium binding domain of αIIb prevents maturation of the αIIbβ3 integrin complex. J Biol Chem. 1994;269:4450-4457.
43. Wilcox DA, Paddock CM, Lyman S, Gill JC, Newman PJ. Glanzmann thrombasthenia resulting from a single amino acid substitution between the second and third calcium-binding domains of GPIIb: role of the GPIIb amino terminus in integrin subunit association. J Clin Invest. 1995;95: 1553-1560.
44. Rosa JP, McEver RP. Processing and assembly of the integrin, glycoprotein IIb-IIIa, in HEL cells. J Biol Chem. 1989;264:12,596-12,603.
45. O'Toole TE, Loftus JC, Plow EF, Glass AA, Harper KR, Ginsberg MH. Efficient surface expression of platelet GPIIb-IIIa requires both subunits. Blood. 1989;74:14-18.
46. D'Souza SE, Ginsberg MH, Burke TA, Plow EF. The ligand binding site of the platelet integrin receptor GPIIb-IIIa is proximal to the second calcium binding domain of its alpha subunit. J Biol Chem. 1990;265:3440-3446.
47. Loftus JC, Halloran CE, Ginsberg MH, Feigen LP, Zablocki JA, Smith JW. The amino-terminal one-third of alpha IIb defines the ligand recognition specificity of integrin alpha IIb beta 3. J Biol Chem. 1996;271:2033-2039.
48. Loftus JC, Liddington RC. Cell adhesion in vascular biology: new insights into integrin-ligand interaction. J Clin Invest. 1997;99:2302-2306.
49. Oxvig C, Springer TA. Experimental support for a beta-propeller domain in integrin alpha-subunits and a calcium binding site on its lower surface. Proc Natl Acad Si U S A. 1998;95:4870-4875.
50. Lu C, Oxvig C, Springer TA. The structure of the beta-propeller domain and C-terminal region of the integrin alphaM subunit: dependence on beta subunit association and prediction of domains. J Biol Chem. 1998;273:15,138-15,147.
51. Baneres JL, Roquet F, Green M, LeCalvez H, Parello J. The cation-binding domain from the alpha subunit of integrin alpha5 beta1 is a minimal domain for fibronectin recognition. J Biol Chem. 1998;273:24,744-24,753.
52. Wang R, Shattil SJ, Ambruso DR, Newman PJ. Truncation of the cytoplasmic domain of beta3 in a variant form of Glanzmann thrombasthenia abrogates signaling through the integrin alphaIIb-beta3 complex. J Clin Invest. 1997;100:2393-2403.